ISRCTN12125882 - Influence of topical anti-VEGF (Ranibizumab) on the outcome of filtration surgery for glaucoma - Study Protocol

BACKGROUND: Excessive wound healing, with scarring of the episcleral tissue or encapsulation of the filtering bleb is the main reason for failure in trabeculectomy. Ranibizumab, an inhibitor of the Vascular Endothelial Growth Factor (VEGF), is seen as a promising candidate to prevent or treat extens...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bochmann, Frank, Kaufmann, Claude, Becht, Christoph N, Guber, Ivo, Kaiser, Michael, Bachmann, Lucas M, Thiel, Michael A
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2011
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3034719/
https://ncbi.nlm.nih.gov/pubmed/21241468
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2415-11-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados